M. Zwirner

1.0k total citations
29 papers, 751 citations indexed

About

M. Zwirner is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, M. Zwirner has authored 29 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 7 papers in Reproductive Medicine and 6 papers in Molecular Biology. Recurrent topics in M. Zwirner's work include Reproductive Biology and Fertility (4 papers), Ovarian cancer diagnosis and treatment (3 papers) and Estrogen and related hormone effects (3 papers). M. Zwirner is often cited by papers focused on Reproductive Biology and Fertility (4 papers), Ovarian cancer diagnosis and treatment (3 papers) and Estrogen and related hormone effects (3 papers). M. Zwirner collaborates with scholars based in Germany, Netherlands and Denmark. M. Zwirner's co-authors include Gordon Rustin, Michael J. Duffy, György Sölétormos, J Kulpa, G. C. Torre, Malgorzata Tuxen, J. M. G. Bonfrer, D. Wallwiener, Harald Seeger and M Starlinger and has published in prestigious journals such as Journal of Clinical Oncology, Chemosphere and Human Reproduction.

In The Last Decade

M. Zwirner

28 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Zwirner Germany 13 222 133 128 115 108 29 751
J. Rajput-Williams United Kingdom 9 191 0.9× 284 2.1× 98 0.8× 108 0.9× 41 0.4× 15 683
John E. Nichols United States 17 365 1.6× 214 1.6× 58 0.5× 264 2.3× 215 2.0× 36 1.0k
Ch. Bieglmayer Austria 15 128 0.6× 147 1.1× 187 1.5× 100 0.9× 68 0.6× 45 818
Olivia Trummer Austria 14 221 1.0× 221 1.7× 45 0.4× 58 0.5× 65 0.6× 28 700
Y Kashimura Japan 10 194 0.9× 235 1.8× 40 0.3× 134 1.2× 57 0.5× 26 718
George Christodoulakos Greece 21 423 1.9× 135 1.0× 90 0.7× 240 2.1× 173 1.6× 55 1.3k
Bénazir Siddeek France 18 90 0.4× 414 3.1× 141 1.1× 130 1.1× 154 1.4× 30 1.1k
Alice Wang United States 16 106 0.5× 377 2.8× 46 0.4× 79 0.7× 116 1.1× 35 933
Pekka Leinonen Finland 15 99 0.4× 305 2.3× 100 0.8× 96 0.8× 105 1.0× 27 1.1k
Esther Dos Santos France 18 133 0.6× 200 1.5× 42 0.3× 88 0.8× 151 1.4× 33 1.1k

Countries citing papers authored by M. Zwirner

Since Specialization
Citations

This map shows the geographic impact of M. Zwirner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Zwirner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Zwirner more than expected).

Fields of papers citing papers by M. Zwirner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Zwirner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Zwirner. The network helps show where M. Zwirner may publish in the future.

Co-authorship network of co-authors of M. Zwirner

This figure shows the co-authorship network connecting the top 25 collaborators of M. Zwirner. A scholar is included among the top collaborators of M. Zwirner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Zwirner. M. Zwirner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fehm, Tanja, M. Zwirner, D. Wallwiener, Harald Seeger, & Hans Neubauer. (2012). Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay. BMC Cancer. 12(1). 308–308. 14 indexed citations
2.
Reinsberg, J., Thomas Bertsch, Mohammad Emami, et al.. (2009). Precision and long-term stability of different estradiol immunoassays assessed in a multi-center quality control study.. PubMed. 55(5-6). 201–6. 10 indexed citations
3.
Jarczok, Tomasz A., et al.. (2009). Progesterone and 5α-Pregnane-3, 20-dione in Human Amniotic Fluid. Experimental and Clinical Endocrinology & Diabetes. 89(1). 39–47.
4.
Neubauer, Hans, Erich Solomayer, Christoph Meisner, et al.. (2008). Predicting resistance to platinum-containing chemotherapy with the ATP tumor chemosensitivity assay in primary ovarian cancer.. PubMed. 28(2A). 949–55. 28 indexed citations
5.
Fluhr, Herbert, et al.. (2006). Human chorionic gonadotropin inhibits insulin-like growth factor–binding protein-1 and prolactin in decidualized human endometrial stromal cells. Fertility and Sterility. 86(1). 236–238. 41 indexed citations
6.
Duffy, Michael J., J. M. G. Bonfrer, J Kulpa, et al.. (2005). CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use. International Journal of Gynecological Cancer. 15(5). 679–691. 222 indexed citations
7.
Duffy, Michael J., Johannes M.G. Bonfrèr, J Kulpa, et al.. (2005). CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use. International Journal of Gynecological Cancer. 15(5). 679–691. 29 indexed citations
8.
Orlikowsky, Thorsten, Felix Neunhoeffer, Rangmar Goelz, et al.. (2004). Evaluation of IL-8-Concentrations in Plasma and Lysed EDTA-Blood in Healthy Neonates and Those with Suspected Early Onset Bacterial Infection. Pediatric Research. 56(5). 804–809. 38 indexed citations
9.
Prange‐Kiel, Janine, Gabriele M. Rune, M. Zwirner, D. Wallwiener, & Ludwig Kiesel. (2001). Regulation of estrogen receptor α and progesterone receptor (isoform A and B) expression in cultured human endometrial cells. Experimental and Clinical Endocrinology & Diabetes. 109(4). 231–237. 32 indexed citations
10.
Čulig, Zoran, K.-H. Bichler, A. van Dalen, et al.. (1998). Scientific Communication. LaboratoriumsMedizin. 22(6). 354–362. 1 indexed citations
11.
Körner, Wolfgang, et al.. (1998). Validation and application of a rapid in vitro assay for assessing the estrogenic potency of halogenated phenolic chemicals. Chemosphere. 37(9-12). 2395–2407. 78 indexed citations
12.
Maier, Gerhard, et al.. (1997). High prevalence of bone disorders after gastrectomy. The American Journal of Surgery. 174(4). 431–438. 112 indexed citations
13.
Lippert, T. H., et al.. (1996). Serotonin metabolite excretion after postmenopausal estradiol therapy. Maturitas. 24(1-2). 37–41. 44 indexed citations
14.
Ertl, Tibor, Á. Török, József Bódis, et al.. (1993). Spontaneous and gonadotropin-releasing hormone induced human chorionic gonadotropin release from superfused JAR choriocarcinoma cells. Archives of Gynecology and Obstetrics. 253(1). 43–49. 5 indexed citations
15.
Zwirner, M., et al.. (1992). Androgen response in polycystic ovarian syndrome to FSH treatment after LHRH agonist suppression.. PubMed. 37(3). 171–5. 6 indexed citations
16.
17.
Zwirner, M., et al.. (1990). An International Proficiency Study with the Tumor Marker CA 125. The International Journal of Biological Markers. 5(2). 55–60. 2 indexed citations
18.
Seeger, Harald, M. Zwirner, Wolfgang Voelter, & T. H. Lippert. (1988). Relaxin and Human Chorionic Gonadotropin Concentrations in Blood Serum during the First Trimester of Normal and Pathological Pregnancy. Gynecologic and Obstetric Investigation. 25(3). 209–212. 3 indexed citations
19.
Zwirner, M., et al.. (1983). Radioimmunoassay of 5α-Pregnane-3,20-Dione. Archives of Gynecology and Obstetrics. 233(4). 229–240. 1 indexed citations
20.
Zwirner, M., et al.. (1982). Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.. PubMed. 32(7). 787–91. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Rajput-Williams Breakdown of academic impact, for papers by John E. Nichols Breakdown of academic impact, for papers by Ch. Bieglmayer Breakdown of academic impact, for papers by Olivia Trummer Breakdown of academic impact, for papers by Y Kashimura Breakdown of academic impact, for papers by George Christodoulakos Breakdown of academic impact, for papers by Bénazir Siddeek Breakdown of academic impact, for papers by Alice Wang Breakdown of academic impact, for papers by Pekka Leinonen Breakdown of academic impact, for papers by Esther Dos Santos
Rankless by CCL
2026